Obesity, a worldwide epidemic, confers increased risk for multiple serious conditions, including type 2 diabetes, cardiovascular diseases, nonalcoholic fatty liver disease and cancer. Adipose tissue is considered one of the largest endocrine organs in the body as well as an active tissue for cellular reactions and metabolic homeostasis rather than an inert tissue for energy storage. The functional pleiotropism of adipose tissue relies on its ability to synthesize and release a large number of hormones, cytokines, extracellular matrix proteins and growth and vasoactive factors, collectively termed adipokines that influence a variety of physiological and pathophysiological processes. In the obese state, excessive visceral fat accumulation causes adipose tissue dysfunctionality that strongly contributes to the onset of obesity-related comorbidities. The mechanisms underlying adipose tissue dysfunction include adipocyte hypertrophy and hyperplasia, increased inflammation, impaired extracellular matrix remodelling and fibrosis together with an altered secretion of adipokines. This review describes how adipose tissue becomes inflamed in obesity and summarizes key players and molecular mechanisms involved in adipose inflammation.
the adipose tissue was considered as a long-term energy storage organ from which free fatty acids are released during fasting to fuel the energy demands of the organism. Currently, the view of the adipose tissue has significantly changed and it is now recognized as a complex and dynamic endocrine organ with an intricate role in whole body homeostasis. 16, 17 The adipocytes are metabolically active and potent secretory cells capable of releasing a large number of adipokines involved in the regulation of appetite, inflammatory and immune functions, glucose and lipid metabolism, cardiovascular homeostasis and reproduction, among other important biological and physiological functions. [18] [19] [20] Adipose tissue from obese subjects undergoes different cellular and structural remodelling processes to adapt the excessive caloric intake including 21 : (a) adipose tissue expansion through regulation of adipocyte hyperplasia (increase in cell number) and hypertrophy (increase in cell size) 22 , (b) immune cells infiltration into the adipose tissue 23, 24 and (c) extracellular matrix (ECM) remodelling to allow adequate tissue expansion. 25 It is widely accepted that sustained obesity as well as chronic and unresolved inflammation are associated with an imbalance of these adaptive homeostatic mechanisms, leading to adipose tissue dysfunctionality 21, 26 characterized by altered secretion of adipokines with a special upregulation in the expression of proinflammatory adipokines 27 , excessive lipid storage and adipogenesis as well as impaired angiogenesis, local hypoxia and fibrosis. 28, 29 These metabolic alterations and the limitation in adipose tissue expandability negatively affect the correct function of adipose tissue affecting global metabolic homeostasis and leading to ectopic fat accumulation with lipotoxic consequences 26 ( Figure 1 ). In this regard, the anatomical distribution of the different fat depots inside the human body determines their metabolic identity and physiological roles being also an important factor influencing the development of obesity-associated comorbidities. 30, 31 In humans, white adipose tissue (WAT) 
| The innate immune system
Extensive research linking inflammation and metabolic disease has focused on the role of the innate immune response. 34 The innate immune system serves as the body's first line of defence in response to injury or pathogens. This system comprises cells from myeloid lineages being monocytes and macrophages the most representative cell types. 42 These cellular types constitute the largest proportion of the stromovascular cell fraction in adipose tissue playing key roles in promoting the obesity-associated inflammatory signalling. 43 Other cells from the innate system also infiltrate the adipose tissue including dendritic cells, mast cells, natural killer cells and granulocytes (basophils, eosinophils and neutrophils). 37, [44] [45] [46] [47] Neutrophils have been involved in the establishment of the obesityassociated chronic inflammatory state and in the promotion of insulin resistance mainly through elastase production, 37 whereas eosinophils and myeloid-derived suppressor cells have been suggested to play a protective role being one of the main source of interleukin (IL)-4 and IL-13 in WAT. 48, 49 Macrophages are a heterogeneous population and based on their cytokine profile secretion and cell surface markers, adipose tissue macrophages (ATM) are classified into two main types: M1 or "classically activated" macrophages and "alternatively activated" macrophages named M2. 39 53, 64 and the decrease in ATM infiltration is linked with an improvement in glucose homoeostasis after weight loss. 
| The adaptive immune system
Recent advances in the field of adipose tissue biology point to a prominent role of the adaptive immune system in adipose tissue inflammation. 66 Lymphoid cells account for up to 10% cells of the stromal vascular fraction in human adipose tissue 38 Furthermore, the increased number of Th1 cells present in VAT may contribute to local inflammatory cell activation before the appearance of macrophages, suggesting an important role for these cells in the initiation and perpetuation of adipose tissue inflammation as well as the development of insulin resistance. 72 The depletion of Treg cells in VAT has been associated with inflammation in obesity in both rodents and humans, 73 together with an increased infiltration of T cells and NK cells. 74 The role of B lymphocytes in the regulation of adipose tissue inflammation and glucose homeostasis is less clear, despite the evidence that in mice, these cells are recruited to adipose tissue before T cells, shortly after the initiation of a high-fat diet (HFD) 75 and that Bcell activation is increased in individuals with T2D. 76 Moreover, a dysregulated function of Toll-like receptors in B cells from patients with T2D promoting inflammation by the elevation of the proinflammatory cytokine IL-8 and the lack of anti-inflammatory/protective IL-10 production has been shown. 76 
and include T cells, B cells, natural killer cells (NK), natural killer T cells (NKT) and type 2 innate lymphoid cells (ILC2

| ADIPOSE TISSUE
INFLAMMATION AND DYSREGULATED ADIPOKINE PROFILE IN OBESITY
Metabolic disease-associated inflammation or metaflammation is found in numerous tissues involved in nutrient regulation. [77] [78] [79] Since the early 1970s, adipose tissue has been recognized as a nexus between inflammation and metabolism and the finding that TNF-α was highly induced in the adipose tissue of obese mice and humans, 80, 81 with adipocytes being a predominant source of this cytokine, provided the first clear link between obesity, diabetes and chronic inflammation. 82 This fact initiated a great number of studies that have revealed complex and integrated adipose tissue inflammatory signalling pathways that contribute to the disruption of the metabolic homeostasis. 63, 83, 84 Interestingly, inflammation has been shown to be required for a proper adipose tissue expansion and remodelling in three different mouse models under a HFD challenge in the initial stages, exerting a positive impact on metabolism. 85 However, a chronic state of insulin resistance in established obesity has been reported to be mediated by macrophageinduced proinflammatory actions. 86 The trigger for adipose tissue inflammation could be initiated from different intrinsic signals including gut-derived substances, adipocyte death and hypoxia, mechanotransduction arising from ECM remodelling as well as adipokine dysregulation. 77 The important role of proinflammatory cytokine secretion from adipose tissue has been consistently associated with the risk of adverse outcomes in obesity-linked complications, promoting a persistent, low-grade, inflammatory response. Accordingly, adipokines are considered as regulators of whole body homeostasis. 27 In addition to leptin, TNF-α, IL-6, resistin and adiponectin, extensively reviewed, [87] [88] [89] [90] [91] other key adipokines involved in the regulation of inflammation have been identified. 92, 93 Our group has contributed to the identification of a number of emerging factors in relation with adipobiology. Wingless-type MMTV integration site family 5A (WNT-5A) is an entangled molecule that primarily signals through the Wnt noncanonical pathway, a β-catenin-independent pathway mainly associated with the promotion of the inflammatory response in adipose tissue. 94 Different evidences indicaxte that WNT-5A exhibits antiadipogenic functions 95 and proinflammatory actions 96 . Additionally, a role for WNT signalling in the regulation of body fat distribution has been also proposed. 97 Increased circulating concentrations of WNT-5A in obese patients with and without T2D have been shown to be reduced after weight loss achieved by Roux-en-Y gastric bypass, a type of bariatric surgery with proven effects on metabolic improvement and obesity resolution. 98 The secreted frizzled-related protein (SFRP) 5 has been shown to bind and antagonize WNT5A, thus inhibiting its downstream noncanonical signalling pathway and emerging as an anti-inflammatory adipokine that modulates metabolic dysfunction in obese mice as well as an important mediator of insulin resistance and adipose tissue inflammation in humans. 98, 99 In this sense, the treatment of visceral adipocytes with SFRP-5 blunted the WNT-5A-induced expression of inflammatory genes, strengthening the role for SFRP5 as an anti-inflammatory factor ( Figure 2 ).
98
Lipocalin 2 (LCN-2) is a 25 kDa glycoprotein member of the highly heterogeneous family of lipocalins. LCN-2 is a component of the innate immune system with a relevant role in the acute-phase response to infection as well in as the induction of apoptosis. 100 LCN-2 is expressed in metabolic tissues including adipose tissue and liver. Recent reports have identified LCN-2 as an adipokine closely related to obesity and insulin resistance with increased expression levels in obese diabetic db/db mice 101 and isolated adipocytes from obese Zucker rats. 102 Furthermore, increased gene and protein expression levels of LCN-2 in VAT have been described in human obesity. 103 Accordingly, increased circulating and gene expression levels of LCN2 in human peripheral mononuclear cells in obesity as well as a positive association with insulin levels and HOMA index have been identified. 104 The development of obesity is associated with modifications in adipose tissue ECM and the matrix metalloproteinase (MMP) system actively contributes to this process. 105 In this regard, LCN-2 has been described to exert a protective effect on MMP-9, preventing the latter from degradation in both cell cultures and human VAT.
103,106
Chitinase-3-like protein 1 (CHI3L1) also known as YKL-40 or human cartilage glycoprotein-39 is involved in the activation of the innate immune system and plays important functions in tissue inflammation and extracellular matrix remodelling. Noteworthy, YKL-40 is a growth factor with key functions in the carcinogenesis of obesityassociated colon cancer. 107 Chemerin or retinoic acid receptor responder 2 (RARRES2) is an adipokine with important roles in the regulation of adipogenesis and glucose metabolism as well as in the initiation of immune responses by regulating leucocyte recruitment towards the site of inflammation. 112, 113 Chemerin and its receptor, the chemokine-like receptor 1 
F I G U R E 4
Adipose tissue is a dynamic endocrine system key in the regulation of whole body energy homeostasis through the secretion of large number of cytokines, hormones and other inflammatory markers, collectively termed adipokines. During obesity, adipose tissue becomes severely dysfunctional accompanied by changes in the secretion profile of adipokines, with a special upregulation of proinflammatory adipokines (Calprotectin, CHI3L1/ YKL40, IL-32, OPN, RARRES2, TNC, Visfatin and WNT-5A) and a downregulation of anti-inflammatory adipokines (FGF21, SFRP5 and LCN-2). This alteration affects the appropriate adipose tissue expansion to store the surplus energy being associated with disrupted metabolic homeostasis and promoting the obesity-associated metabolic alterations. CHI3L1/YKL40, chitinase-3-like protein 1; FGF21, fibroblast growth factor 21; IL-32, interleukin-32; LCN-2, lipocalin 2; OPN, osteopontin; RARRES2, chemerin; SFRP5, secreted frizzled-related protein 5; TNC, tenascin C; WNT-5A, wingless-type MMTV integration site family 5A UNAMUNO ET AL.
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(CMKLR1) are highly expressed in adipose tissue and different studies have shown an association with markers of the metabolic syndrome and inflammation. 114 Indeed, TNF-α treatment significantly enhances the gene expression levels of chemerin in human visceral adipocytes. However, recent data point towards more complex activities either pro-or anti-inflammatory, depending on the disease model. 115 In this regard, low chemerin expression in adipose tissue of db/db mice 116 and an anti-inflammatory effect depending on the protease that cleavages prochemerin 117 have been reported.
Tenascin C (TNC) is an adhesion-modulating extracellular matrix glycoprotein that belongs to the damage-associated molecular patterns (DAMPs) family and its de novo expression is a hallmark of inflammation. 118 The expression pattern of TNC is dynamic, being specifically induced and tightly regulated during acute inflammation and permanently expressed in chronic inflammation. 119 TNC binds to different ligand types including fibronectin, collagen, periostin and fibrillin-2. 118 In this line, TNC has been identified as the endogenous activator of Toll-like receptor (TLR)-4, whose activation promotes innate and adaptive immune responses as well as the expression of procollagen type 1 and integrin-1β. 120 Interestingly, increased levels of TNC in the VAT of obese subjects with or without T2D as well as in obese volunteers with NAFLD have been reported. 121 Consistently, the adipose tissue gene expression levels of Tnc are also increased in murine models of obesity. 121, 122 Calprotectin is a 24-kDa heterodimer comprising the S100A8 (calgranulin A, MRP8) and S100A9 (calgranulin B, MRP14) subunits, which are low molecular weight members of a subfamily of S100 calcium-binding proteins called calgranulins. 123 The S100A8/A9 complex can be found in two major forms, a secreted soluble form and a plasmatic membrane integrated form. 124 Calprotectin represents an interesting peptide involved in the pathophysiology of various inflammatory processes, including rheumatoid arthritis, allograft rejections, inflammatory bowel disease, cancer and cardiovascular diseases. 20 In line with this function, calprotectin is defined as a DAMP. Recently, calprotectin has been considered an adipokine and a novel marker of obesity, with its circulating and VAT expression levels being increased in obesity as well as in T1D and T2D. [125] [126] [127] Fibroblast growth factor 21 (FGF21) is mainly produced by the liver and the adipose tissue under different stressful conditions. 128 It has pleiotropic actions related to energy homeostasis, which are mediated through the fibroblast growth factor receptor (FGFR) and β-Klotho coreceptor, representing a potential pharmaceutical target in the treatment of obesity and its associated comorbidities. 129 A recent study has reported that ob/ob and diet-induced obese mice exhibited elevated circulating levels of FGF21, being also less sensitive to exogenous FGF21 administration. 130 Circulating levels of FGF21 have been shown to be increased in obesity being further increased in obesity-associated T2D and also correlated with the glycaemic level. 131, 132 Importantly, FGF21 levels were reduced after diet-or surgically induced weight loss. 132 Interleukin-32 (IL-32), also termed as TNF-α-inducing factor and natural killer cell transcript (NK)-4, is a recently described cytokine produced by immune and nonimmune cells including natural killer cells, monocytes, macrophages, T lymphocytes, fibroblasts as well as epithelial and endothelial cells. 133, 134 IL-32 exerts important roles in the pathogenesis of infectious, autoimmune and inflammatory diseases. 135 Increased IL-32 expression has been found in VAT from patients with obesity promoting inflammation and ECM remodelling and contributing to the development of obesity-associated comorbidities. 136 Reportedly, the increased circulating levels of IL-32 in human obesity and obesity-associated T2D decrease after weight loss. 136 Previous studies have demonstrated that inflammatory cytokines such as IL-1β, interferon (IFN)-γ or TNF-α induce the expression of IL-32 and, in turn, IL-32 also stimulates IL-8, IL-6, IL-1β and TNF-α production, constituting a classical proinflammatory mediator with relevant functions in angiogenesis, ECM remodelling and apoptosis ( Figure 3 ). In this sense, a potential involvement of IL-32 in the development of obesity-associated colon cancer as a proinflammatory and ECM remodelling cytokine has been proposed. 137 
| CONCLUSION
A central process involved in the etiopathogenesis of obesity is the dysfunctional adipose tissue characterized by adipocyte hypertrophy, exacerbated inflammation, increased fibrosis and impaired vascular function and structure. Adipose tissue influence and communicate with many other organs by releasing pro-or anti-inflammatory bioactive molecules named adipokines. Extensive experimentation in both animal models and humans has demonstrated that an altered expression of these molecules, promoted by obesity or adipocyte dysregulation, plays critical roles for impairing whole body homeostasis contributing to the initiation and progression of obesity-induced metabolic complications ( Figure 4 ). The presence of immune cells, such as macrophages, in metabolic tissues suggests a dynamic and ongoing crosstalk between metabolism and immunity, contributing to the obesity-associated inflammation. In the light of the fact that the prevalence of obesity is expected to increase in the coming decades, a more detailed study of the functions and mechanisms of key adipokines will permit a better understanding of the pathogenesis of obesitylinked disorders as well as more focused therapies for the management of obesity and its complications. 138 Furthermore, while some adipokines have been deeply studied, new adipokines continue to be discovered and elucidated. Thinking beyond metabolic function of adipose tissue constitutes a relevant concept because different disease areas may be affected by adipocytes. 139 
